3-CMC
Description
3-CMC, also known as 3-Chloromethcathinone or Clophedrone, is a research chemical from the cathinone family. It is similar in structure to other cathinone drugs like mephedrone and 3-MMC, and is often used as a recreational drug. 3-CMC is known for its stimulating and euphoric effects, and is often compared to cocaine.
Physical Effects
3-CMC acts as a dopamine-norepinephrine reuptake inhibitor (NDRI), which leads to an increase in the levels of dopamine and norepinephrine in the brain. This, in turn, produces a stimulating effect that can help users feel more alert and focused. Users may also experience increased sociability, heightened energy and alertness, and a sense of well-being. However, it can also cause negative effects such as increased heart rate, anxiety, and sweating. 3-CMC is typically found in the form of a white crystalline powder, and is often taken orally or nasally.
Chemistry
3-CMC is a synthetic compound with the chemical formula C10H12ClNO. It has a molar mass of 197.66 g/mol and a melting point of 181-183 °C. 3-CMC is often synthesized from methcathinone and sodium hypochlorite using the Mannich reaction.
Dosing
The appropriate dosage of 3-CMC depends on several factors, including the user’s age, weight, and tolerance to the drug. It is recommended that first-time users start with a small dose of around 20-30mg, and wait at least 2-3 hours before taking another dose. The effects of 3-CMC can last for 2-4 hours.
Effects
3-CMC is known for its stimulating and euphoric effects. However, it can also cause negative effects such as increased heart rate, anxiety, and sweating. Long-term use of 3-CMC can lead to addiction and other health problems, so it is important to use this drug responsibly and in moderation.
At bolchemist.cc, we offer only the highest quality 3-CMC for sale, and we provide fast and discreet shipping to ensure your privacy. Buy 3-CMC from us and experience the benefits of a reliable and trustworthy online research chemical supplier.
Reviews
There are no reviews yet.